4//SEC Filing
HURWITZ EDWARD 4
Accession 0000950170-25-081360
CIK 0001818794other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 9:41 PM ET
Size
15.2 KB
Accession
0000950170-25-081360
Insider Transaction Report
Form 4
HURWITZ EDWARD
Director
Transactions
- Award
Stock option (right to buy)
2025-05-30+35,000→ 35,000 totalExercise: $11.96Exp: 2035-05-29→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 30, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 30, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001211840
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 9:41 PM ET
- Size
- 15.2 KB